After completing this educational activity, learners will be able to:

• Match T2D agents to specific patient presentations, with varying needs such as weight loss or presence of cardiovascular disease
  
• Acknowledge appropriate glycaemic, weight and cardiorenal targets and describe their importance
• Acknowledge the effect of social, cultural and religious values and beliefs on choice of diabetes care, and discuss strategies to mitigate these

Chair: Professor Francesco Giorgino

Guest for "Highlights from ADA 2023": Dr. Richard Pratley

Guest for "Striving for Balance: Achieving Glycemic, Weight, and Cardiorenal Targets in T2D Care": Dr. Vanita Aroda

Guest for "Congress special: Highlights from EASD 2023": Dr Erika Bezerra Parente

Guest for "World Diabetes Day – Overcoming Cultural Obstacles to Personalise Diabetes Care": Dr. Alice Cheng

Guest for "Effective strategies for encouraging behaviour change in people with diabetes and strong religious, cultural or social values": Dr. Shehla Shaikh

Dr. Shehla Shaikh has no financial relationships to disclose

Guest for "Personalisation of therapy for people with type 2 diabetes and cardiovascular disease risk": Dr. Darren McGuire

Staff Disclosures

Liberum IME staff, ACHL staff and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.

ACHL requires that the faculty participating in an accredited continuing education activity disclose all affiliations or other financial relationships within 24 months (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any ineligible companies. All relevant financial relationships have been mitigated prior to this activity. 

This CME/CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires its speakers to disclose that a product is not labeled for the use under discussion.

Discussion of Off-Label, Investigational, or Experimental Drug Use: none

This independent educational activity is supported by an educational grant from Novo Nordisk A/S. The educational content has been developed by Liberum IME in conjunction with an independent steering committee; Novo Nordisk A/S, has had no influence on the content of this education.

Episode 1: Highlights from ADA 2023

This episode was accredited on the 12th September 2023 and will expire on the 12th September 2024.

Episode 2: Striving for Balance: Achieving Glycemic, Weight, and Cardiorenal Targets in T2D Care

This episode was accredited on the 28th September 2023 and will expire on the 28th September 2024.

Episode 3: Congress special: Highlights from EASD 2023

This episode was accredited on the 11th December 2023 and will expire on the 11th December 2024.

Episode 4: World Diabetes Day – Overcoming Cultural Obstacles to Personalise Diabetes Care

This episode was accredited on the 19th December 2023 and will expire on the 19th December 2024.

Episode 5: Effective strategies for encouraging behaviour change in people with diabetes and strong religious, cultural or social values

This episode was accredited on the 14th February 2024 and will expire on the 14th Feburary 2025.

Episode 6: Personalisation of therapy for people with type 2 diabetes and cardiovascular disease risk

This episode was accredited on the 14th February 2024 and will expire on the 14th Feburary 2025.

The information and data provided in this program was updated and correct at the time of the program development, but may be subject to change.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Academy for Continued Healthcare Learning (ACHL) and Liberum IME. ACHL is accredited by the ACCME to provide continuing medical education for physicians.

 The Academy for Continued Healthcare Learning (ACHL) designates each enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim credit commensurate with the extent of their participation in the activity.

The American Medical Association (AMA) has an agreement of mutual recognition of Continuing Medical Education (CME) credits with the European Union of Medical Specialists (UEMS), the accreditation body for European countries. Physicians interested in converting AMA PRA Category 1 Credit™ to UEMS-European Accreditation Council for Continuing Medical Education CME credits (ECMEC®s) should contact the UEMS at mutualrecognition@uems.eu

The content for this activity was developed independently of the ineligible companies. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantors. 

This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.